Smart Design of Neoantigen Vaccine Clinical Development
Time: 4:45 pm
day: Day One
Details:
- Selecting the cancer type, disease setting and patient subpopulation
- Determining dosing schedules, mode of administration and alignment with standard of care
- Deciding on endpoints of immune and clinical response to demonstrate improvements over standard of care
